The United States Pharmacopeia emphasizes mechanical calibration and a performance test to esnure integrity of the dissolution procedure. In October 2007, the USFood and Drug Administration released a ...
When it comes to dissolution testing, research is focusing on ways to extend its reach, improve in-vitro and in-vivo correlation, and make real-time release testing a reality. Studying how a drug ...
Key market opportunities in dissolution testing include optimizing drug bioavailability and enhancing quality control to meet regulatory demands. Understanding scientific principles and regulatory ...
Dissolution and drug release tests are directly relevant to the safety and efficacy of many common pharmaceutical dosage forms. To achieve reliable and reproducible results, analysts must understand ...
Teva is voluntarily recalling a single lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure that was detected during a routine stability test. Teva is voluntarily recalling a single lot ...
The new Inhaled Dissolution Dose Collector (IDDC) from Copley Scientific is a flexible, easy-to-use system for collecting the respirable fraction of the dose delivered by a metered dose or dry powder ...
In order to highlight the importance of dissolution testing in pharmaceutical industry as a tool in drug development and quality control, Society for Pharmaceutical Dissolution Science (SPDS) ...
Teva Pharmaceuticals USA has initiated a voluntary nationwide recall of a single lot of Anagrelide Capsules, USP 0.5 mg (Lot number GD01090), to the consumer level in the United States. This voluntary ...
In addition to use of dissolution testers, this three-day course will also cover equipment qualification, development and validation of dissolution procedures, and the use of dissolution testing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback